Allyx Therapeutics, Inc.

Form D Filings

Date Filed Security Types Total Amount Sold Total Offering Amount Remaining First Sale Signed Form SEC Link
3/3/2026 Option to Acquire, Other $3,324,918 $4,000,000 $675,082 2/23/2026 3/3/2026 D 000186525726000003
2/10/2023 Equity $2,308,569 $2,308,569 $0 2/3/2023 2/9/2023 D 000186525723000001
6/2/2021 Equity $7,581,493 $8,031,491 $449,998 5/26/2021 6/1/2021 D 000186525721000001